Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2010 | 3 |
2011 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Effect of dutasteride on the risk of prostate cancer.
N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127.
N Engl J Med. 2010.
PMID: 20357281
Free article.
Clinical Trial.
Organisational factors associated with hospital costs and patient mortality in the 365 days following hip fracture in England and Wales (REDUCE): a record-linkage cohort study.
Baji P, Patel R, Judge A, Johansen A, Griffin J, Chesser T, Griffin XL, Javaid MK, Barbosa EC, Ben-Shlomo Y, Marques EMR, Gregson CL; REDUCE Study Group.
Baji P, et al.
Lancet Healthy Longev. 2023 Aug;4(8):e386-e398. doi: 10.1016/S2666-7568(23)00086-7. Epub 2023 Jul 10.
Lancet Healthy Longev. 2023.
PMID: 37442154
Free article.
Item in Clipboard
Patients' recovery of mobility and return to original residence after hip fracture are associated with multiple modifiable components of hospital service organisation: the REDUCE record-linkage cohort study in England and Wales.
Patel R, Judge A, Johansen A, Marques EMR, Chesser T, Griffin XL, Javaid MK; REDUCE Study Group; Ben-Shlomo Y, Gregson CL.
Patel R, et al.
BMC Geriatr. 2023 Jul 27;23(1):459. doi: 10.1186/s12877-023-04038-2.
BMC Geriatr. 2023.
PMID: 37501122
Free PMC article.
Item in Clipboard
Efficacy and safety of dutasteride on prostate cancer risk reduction in Asian men: the results from the REDUCE study.
Akaza H, Kanetake H, Tsukamoto T, Miyanaga N, Sakai H, Masumori N, Nakatsu H, Sagiyama K, Sakamoto S, Endo Y, Yamanouchi T; REDUCE Study Group.
Akaza H, et al.
Jpn J Clin Oncol. 2011 Mar;41(3):417-23. doi: 10.1093/jjco/hyq221. Epub 2010 Dec 1.
Jpn J Clin Oncol. 2011.
PMID: 21123311
Clinical Trial.
Item in Clipboard
The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study.
Andriole GL, Bostwick D, Brawley OW, Gomella L, Marberger M, Montorsi F, Pettaway C, Tammela TL, Teloken C, Tindall D, Freedland SJ, Somerville MC, Wilson TH, Fowler I, Castro R, Rittmaster RS; REDUCE Study Group.
Andriole GL, et al.
J Urol. 2011 Jan;185(1):126-31. doi: 10.1016/j.juro.2010.09.011. Epub 2010 Nov 12.
J Urol. 2011.
PMID: 21074214
Clinical Trial.
Item in Clipboard
Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial.
Andriole G, Bostwick D, Brawley O, Gomella L, Marberger M, Tindall D, Breed S, Somerville M, Rittmaster R; REDUCE Study Group.
Andriole G, et al.
J Urol. 2004 Oct;172(4 Pt 1):1314-7. doi: 10.1097/01.ju.0000139320.78673.2a.
J Urol. 2004.
PMID: 15371831
Clinical Trial.
Item in Clipboard
Cite
Cite